Collingswood, NJ, United States of America

Richard Jiao


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Piscataway, NJ (US) (2004 - 2007)
  • Havertown, PA (US) (2009)
  • Collingswood, NJ (US) (2007 - 2010)

Company Filing History:


Years Active: 2004-2010

Loading Chart...
6 patents (USPTO):

Title: The Innovative Mind of Richard Jiao: Revolutionizing Chemokine Receptor Activity.

Introduction:

Richard Jiao, a distinguished inventor hailing from Collingswood, New Jersey, has been making waves in the field of pharmaceuticals with his groundbreaking work in modulating chemokine receptor activity. With a total of 6 patents under his belt, Jiao's contributions are shaping the future of treatment for various inflammatory and immunoregulatory disorders.

Latest Patents:

Jiao's latest patents showcase his ingenuity in developing Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity. These compounds, outlined in detailed formulas, exhibit significant potential as modulators of the chemokine receptor CCR-2. They hold promise in combating a range of conditions, from allergic diseases to autoimmune pathologies like rheumatoid arthritis and atherosclerosis.

Career Highlights:

Having lent his expertise to renowned companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation, Jiao has left an indelible mark on the pharmaceutical industry. His innovative approach to drug development and his focus on targeting chemokine receptors have garnered him recognition as a trailblazer in his field.

Collaborations:

Jiao's journey towards innovation has been enriched by collaborations with esteemed colleagues such as Lihu Yang and Gregori J. Morriello. Together, they have fostered a culture of creativity and excellence, driving forward projects that hold the potential to transform patient care.

Conclusion:

In conclusion, Richard Jiao's relentless pursuit of excellence and his unwavering commitment to innovation make him a standout figure in the realm of pharmaceutical inventions. His patent portfolio and contributions to the development of novel therapies underscore his status as a visionary inventor. As he continues to push the boundaries of what is possible in modulating chemokine receptor activity, the future looks brighter thanks to his pioneering spirit and dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…